PMVP Pharmaceuticals updates interim ovarian cancer monotherapy data
PMV Pharmaceuticals announced updated interim ovarian cancer data from its PYNNACLE Phase 2 pivotal trial for rezatapopt monotherapy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.